Scope:
Keywords:
Update

News about stocks and BIOD

4 days ago

Analyse the news about stocks and BIOD from multiple sources, get visualizations or extract the entire dataset.

Related dashboards:

This biotech stock is a buy thanks to its cancer treatment pipeline, Citi says

Read on: CNBC News link
23d ago

Buy this biotech stock that can rally more than 65%, Goldman says

Read on: CNBC News link
68d ago

This little-known biotech stock is a buy that's primed to double in price, Goldman says

Read on: CNBC News link
78d ago

This biotech stock is an 'oncology powerhouse' with 40% upside, says Truist Securities

Read on: CNBC News link
85d ago

These innovative biotech stocks have a good chance of breaking out in 2025

Read on: CNBC News link
86d ago

Wells Fargo sees this biotech stock rallying 75% in its bull case

Read on: CNBC News link
124d ago

JPMorgan's top biotech stock picks for 2025 as sector looks for a comeback year

Read on: CNBC News link
128d ago

These 9 biotech stocks have doubled this year and are set to double again, analysts say

Read on: CNBC News link
171d ago

Goldman Sachs says buy this biotech stock with more than 60% upside

Read on: CNBC News link
304d ago

Jim Cramer says don't sell Tesla, but stay away from this biotech stock

Read on: CNBC News link
305d ago

Wells Fargo becomes bullish on this biotech company

Read on: CNBC News link
346d ago

Biotech stocks are ready to break out. They just need one more thing

Read on: CNBC News link
360d ago

M&A Gathers Steam for Biotech Startups

376d ago

Time to 'cut off' US outbound investment in China biotech firms like BGI Group and Wuxi AppTec: House panel

Read on: SCMP link
394d ago

'A trove of rebound opportunities': Strategists turn bullish on biotech and more, picking top stocks

Read on: CNBC News link
445d ago

Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch

Read on: CNBC News link
464d ago

It's Biotech Stocks' Time to Shine

479d ago

It's Biotech Stocks' Time to Shine

480d ago

Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion

Read on: CNBC News link
492d ago

This biotech stock targeting genetically driven diseases could nearly double, predicts JPMorgan

Read on: CNBC News link
494d ago

Dataset

Extract all news on this scope:

Analysis

See the trend on this scope:

Evolution through time

Sources analysis:

Distribution of sources in the news

Sections analysis:

Distribution of sections in the news

Current sentiment polarity: slightly positive with a score of 0.65

positive 70%
neutral 30%

Sentiment polarity through time